Hepatobiliary imaging.
Recent publications continue to refine the technique and interpretation of hepatobiliary scanning. Studies related to the evaluation of suspected acute cholecystitis have shown that morphine-augmented hepatobiliary imaging may not overcome the problem of false-positive study results in severely ill patients and the criterion for a normal study should be gallbladder visualization within 30 rather than 60 minutes. In patients with suspected acute cholecystitis, nonvisualized extrahepatic activity despite good hepatic uptake is highly predictive of acute cholecystitis, usually with biliary obstruction. The limitations of cholecystokinin-hepatobiliary imaging studies in patients with abdominal pain syndromes were defined and its use in evaluating common bile duct dynamics, and duodenogastric reflux was explored. Unusual findings and less-common uses of hepatobiliary scanning were reported, including assessment of conjoined twins, liver transplantation, primary biliary cirrhosis, gallbladder perforation, and persistent splenic visualization.
Watson
A
A
Alfred Hospital, Melbourne, Australia.
Kalff
V
V
D001659:Biliary Tract / Q000000981:diagnostic imaging*; D002764:Cholecystitis / Q000000981:diagnostic imaging; D002766:Cholecystokinin / Q000008:administration & dosage; D004383:Duodenogastric Reflux / Q000000981:diagnostic imaging; D006801:Humans; D007098:Imino Acids; D008099:Liver / Q000000981:diagnostic imaging*; D008105:Liver Cirrhosis, Biliary / Q000000981:diagnostic imaging; D016031:Liver Transplantation; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D014428:Twins, Conjoined
D007098:Imino Acids; D015609:Organotechnetium Compounds; C046767:technetium Tc 99m iminodiacetic acid; D002766:Cholecystokinin